Troleandomycin: Difference between revisions
No edit summary |
No edit summary |
||
Line 54: | Line 54: | ||
| StdInChIKey = LQCLVBQBTUVCEQ-MCQAQMIOSA-N | | StdInChIKey = LQCLVBQBTUVCEQ-MCQAQMIOSA-N | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Troleandomycin''' is a [[macrolide]] antibiotic. It is sold in [[Italy]] (branded '''Triocetin''') and [[Turkey]] (branded '''Tekmisin'''). | '''Troleandomycin''' is a [[macrolide]] antibiotic. It is sold in [[Italy]] (branded '''Triocetin''') and [[Turkey]] (branded '''Tekmisin'''). | ||
Troleandomycin is a [[CYP3A4]] [[enzyme inhibitor|inhibitor]] that may cause [[drug interaction]]s. | Troleandomycin is a [[CYP3A4]] [[enzyme inhibitor|inhibitor]] that may cause [[drug interaction]]s. | ||
==References== | |||
{{Reflist|2}} | |||
{{Macrolides, lincosamides and streptogramins}} | {{Macrolides, lincosamides and streptogramins}} | ||
[[Category:Macrolide antibiotics]] | [[Category:Macrolide antibiotics]] | ||
[[Category:Drug]] | |||
Revision as of 13:29, 9 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | Multum Consumer Information |
MedlinePlus | a604026 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C41H67NO15 |
Molar mass | 813.968 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Troleandomycin |
Articles |
---|
Most recent articles on Troleandomycin Most cited articles on Troleandomycin |
Media |
Powerpoint slides on Troleandomycin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Troleandomycin at Clinical Trials.gov Trial results on Troleandomycin Clinical Trials on Troleandomycin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Troleandomycin NICE Guidance on Troleandomycin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Troleandomycin Discussion groups on Troleandomycin Patient Handouts on Troleandomycin Directions to Hospitals Treating Troleandomycin Risk calculators and risk factors for Troleandomycin
|
Healthcare Provider Resources |
Causes & Risk Factors for Troleandomycin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Troleandomycin is a macrolide antibiotic. It is sold in Italy (branded Triocetin) and Turkey (branded Tekmisin).
Troleandomycin is a CYP3A4 inhibitor that may cause drug interactions.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed KEGG identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Macrolide antibiotics
- Drug